Staying on track: A cluster randomized controlled trial of automated reminders aimed at increasing human papillomavirus vaccine completion

Vaccine

Volumn 32, Issue 21, 2014, Pages 2428-2433

  Patel, Ashlesha ^a,b   Stern, Lisa ^a   Unger, Zoe ^a   Debevec, Elie ^a   Roston, Alicia ^b   Hanover, Rita ^c   Morfesis, Johanna ^a  

^a Planned Parenthood Federation of America ^*  (United States)

^b Jr Hospital of Cook County   (United States)

^c Westport Compass   (United States)

Author keywords

Completion; Human papillomavirus (HPV) vaccine; Information technology; Reminder recalls

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; AUTOMATION; CONTROLLED STUDY; E-MAIL; EXPLORATORY RESEARCH; FEMALE; FOLLOW UP; HEALTH CENTER; HUMAN; MOBILE PHONE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL; REMINDER SYSTEM; REPRODUCTIVE HEALTH; SEXUALITY; SOCIAL NETWORK; TEXT MESSAGING;

COMPLETION; HUMAN PAPILLOMAVIRUS (HPV) VACCINE; INFORMATION TECHNOLOGY; REMINDER-RECALLS;

ADULT; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; PAPILLOMAVIRUS VACCINES; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; REMINDER SYSTEMS; YOUNG ADULT;

EID: 84898426453     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.02.095     Document Type: Article

References (49)

1. U.S.Food and Drug Administration Vaccines, blood, and biologics: Gardasil 2011, Available at: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM094042 [retrieved 19.11.13].
2. U.S.Food and Drug Administration Vaccines, blood, and biologics: Cervarix 2012, Available at: http://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm186957.htm [retrieved 19.11.13].
3. Mendoza N., Hernandez P.O., Tyring S.K. HPV vaccine update: new indications and controversies. Skin Therapy Lett 2011, 16(8):1-3.
4. Tota J.E., Chevarie-Davis M., Richardson L.A., deVries M., Franco E.L. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med 2011, 53:s12-s21. 10.1016/j.ypmed.2011.08.017.
5. Gowda C., Carlos R.C., Butchart A.T., Singer D.C., Davis M.M., Clark S.J., et al. CHIAS: a standardized measure of parental HPV immunization attitudes and beliefs and its associations with vaccine uptake. Sex Transm Dis 2012, 39(6):475-481. 10.1097/OLQ.0b013e318248a6d5.
6. Neubrand T.P., Breitkopf C.R., Rupp R., Breitkopf D., Rosenthal S.L. Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr 2009, 48(9):966-969. 10.1177/0009922809337534.
7. Niccolai L.M., Mehta N.R., Hadler J.L. Racial/ethnic and poverty disparities in human papillomavirus vaccination completion. Am J Prev Med 2011, 41(4):428-433. 10.1016/j.amepre.2011.06.032.
8. Schluterman N.H., Terplan M., Lydecker A.D., Tracy J.K. Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine 2011, 29(21):3767-3772. 10.1016/j.vaccine.2011.03.032.
9. Tan W., Viera A.J., Rowe-West B., Grimshaw A., Quinn B., Walter E.B. The HPV vaccine: are dosing recommendations being followed?. Vaccine 2011, 29(14):2548-2554. 10.1016/j.vaccine.2011.01.066.
10. Widdice L.E., Bernstein D.I., Leonard A.C., Marsolo K.A., Kahn J.A. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics 2011, 127(1):77-84. 10.1542/peds.2010-0812.
11. Rahman M., Laz T.H., Berenson A.B. Geographic variation in human papillomavirus vaccination uptake among young adult women in the United States during 2008-2010. Vaccine 2013, 31(47):5495-5499. 10.1016/j.vaccine.2013.09.022.
12. Centers for Disease Control and Prevention National and state vaccination coverage among adolescents aged 13-17 years - United States, 2012. MMWR Morb Mortal Wkly Rep 2013, 62(August (34)):685-693.
13. Centers for Disease Control and Prevention Estimated vaccination coverage with selected vaccines among adolescents aged 13-17 years by age at interview 2011, National Immunization Survey-Teen, Available at: http://www.cdc.gov/vaccines/stats-surv/nisteen/tables/11/tab03_byage_2011.pdf [retrieved 19.11.13].
14. Chao C., Velicer C., Slezak J.M., Jacobsen S.J. Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc 2009, 84(10):864-870.
15. Schmidt M.A., Gold R., Kurosky M.S., Daley M.F., Irving S.A., Gee J., et al. Uptake, coverage, and completion of the quadrivalent human papillomavirus vaccine in the vaccine safety datalink, July 2006-June 2011. J Adolesc Health 2013, 53:637-641. 10.1016/j.jadohealth.2013.08.002.
16. Hirth J.M., Tan A., Wilkinson G.S., Berenson A.B. Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009. Cancer 2012, 118(22):5623-5629. 10.1002/cncr.27598.
17. Chou B., Krill L.S., Horton B.B., Barat C.E., Trimble C.L. Disparities in human papillomavirus vaccine completion among vaccine initiators. Obstet Gynecol 2011, 118(1):14-20. 10.1097/AOG.0b013e318220ebf3.
18. Wright J.D., Govidappagari S., Pawar N., Cleary K., Burke W.M., Devine P.C., et al. Acceptance and compliance with postpartum human papillomavirus vaccination. Obstet Gynecol 2012, 120(4):771-782.
19. Jacobson Vann J.C., Szilagyi P. Patient reminder and patient recall systems to improve immunization rates. Cochrane Database Syst Rev 2005, (3):CD003941.
20. Jemal A., Simard E.P., Dorell C., Noone A.M., Markowitz L.E., Kohler B., et al. Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV) associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013, 105(3):175-201. 10.1093/jnci/djs491.
21. Cibulka N.J., Fischer H.W., Fischer A.J. Improving communication with low-income women using today's technology. Online J Issues Nurs 2012, 17(2).
22. Car J., Gurol-Urganci I., de Jongh T., Vodopivec-Jamsek V., Atun R. Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database Syst Rev 2012, 7:CD007458. 10.1002/14651858.CD007458.pub2.
23. Hasvold P.E., Wootton R. Use of telephone and SMS reminders to improve attendance at hospital appointments: a systematic review. J Telemed Telecare 2011, 17(7):358-364. 10.1258/jtt.2011.110707.
24. Cassidy B., Braxter B., Charron-Prochownik D., Schlenk E.A. A quality improvement initiative to increase HPV vaccine rates using an educational and reminder strategy with parents of preteen girls. J Pediatr Health Care 2013, pii:S0891-5245(13)00010-2. 10.1016/j.pedhc.2013.01.002.
25. Castaño P.M., Bynum J.Y., Andrés R., Lara M., Westhoff C. Effect of daily text messages on oral contraceptive continuation: a randomized controlled trial. Obstet Gynecol 2012, 119(1):14-20. 10.1097/AOG.0b013e18233d4167.
26. Kharbanda E.O., Stockwell M.S., Fox H.W., Andres R., Lara M., Rickert V.I. Text message reminders to promote human papillomavirus vaccination. Vaccine 2011, 29(14):2537-2541. 10.1016/j.vaccine.2011.01.065.
27. Stockwell M.S., Kharbanda E.O., Martinez R.A., Lara M., Vawdrey D., Natarajan K., et al. Text4Health: impact of text message reminder-recalls for pediatric and adolescent immunizations. Am J Public Health 2012, 102(2):e15-e21. 10.2105/AJPH. 2011.300331.
28. Stockwell M.S., Kharbanda E.O., Martinez R.A., Vargas C.Y., Vawdrey D.K., Camargo S. Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population: a randomized controlled trial. JAMA 2012, 307(16):1702-1708. 10.1001/jama.2012.502.
29. Fiks A.G., Grundmeier R.W., Mayne S., Song L., Feemster K., Karavite D., et al. Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Pediatrics 2013, 131(June (6)):1114-1124. 10.1542/peds.2012-3122.
30. Mayne S., Karavite D., Grundmeier R.W., Localio R., Feemster K., DeBartolo E., et al. The implementation and acceptability of an HPV vaccination decision support system directed at both clinicians and families. AMIA Annu Symp Proc 2012, 2012:616-624.
31. Mazor K.M., Sabin J.E., Boudreau D., Goodman M.J., Gurwitz J.H., Herrinton L.J., et al. Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans. Med Care 2007, 45(10 Suppl. 2):S29-S37.
32. Merck Vaccine Patient Assistance Program 2010, Available at: http://www.merck.com/merckhelps/vaccines/home.html [retrieved 19.11.13].
33. Hayes R.J., Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol 1999, 28(2):319-326.
34. Downs L.S., Scarinci I., Einstein M.H., Collins Y., Flowers L. Overcoming the barriers to HPV vaccination in high-risk populations in the US. Gynecol Oncol 2010, 117(3):486-490. 10.1016/j.ygyno.2010.02.011.
35. Zimet G.D., Perkins S.M., Winston Y., Kee R. Predictors of first and second dose acceptance of hepatitis B vaccine among STD clinic patients. Int J STD AIDS 2008, 19:246-250. 10.1258/ijsa.2007.007136.
36. Dempsey A.F., Schaffer S.E., Cohn L.M. Follow-up analysis of adolescents partially vaccinated against human papillomavirus. J Adolesc Health 2012, 50(4):421-423. 10.1016/j.jadohealth.2011.08.017.
37. U.S.Census Bureau 2011 American Community Survey 2013, Available at: http://factfinder2.census.gov/faces/tableservices/jsf/pages/productview.xhtml?pid=ACS_11_1YR_B07001&prodType=table [retrieved 19.11.13].
38. Lustria M.L.A., Cortese J., Noar S.M., Glueckauf R.L. Computer-tailored health interventions delivered over the web: review and analysis of key components. Patient Educ Couns 2009, 74(2):156-173. 10.1016/j.pec.2008.08.023.
39. Markowitz L.E., Hariri S., Lin C., Dunne E.F., Steinau M., McQuillan F., et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States. National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis 2013, 208(3):385-393. 10.1093/infdis/jit192.
40. Kessels S.J.M., Marshall H.S., Watson M., Braunack-Mayer A.J., Reuzel R., Tooher R.L. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine 2012, 30(24):3546-3556. 10.1016/j.vaccine.2012.03.063.
41. Etter D.J., Zimet G.D., Rickert V.I. Human papillomavirus vaccine in adolescent women: a 2012 update. Curr Opin Obstet Gynecol 2012, 24(5):305-310. 10.1097/GCO.0b013e3283567005.
42. Poole T., Goodyear-Smith F., Petousis-Harris H., Desmond N., Exeter D., Pointon L., et al. Human papillomavirus vaccination in Auckland: reducing ethnic and socioeconomic inequities. Vaccine 2012, 31(1):84-88. 10.1016/j.vaccine.2012.10.099.
43. Kreimer A.R., Rodriguez A.C., Hildesheim A., Herrero R., Porras C., Schiffman M., et al. Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. J Natl Cancer Inst 2011, 103(19):1444-1451. 10.1093/jnci/djr319.
44. Dobson S.R., McNeil S., Dionne M., Dawar M., Ogilvie G., Krajden M., et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA 2013, 309(17):1793-1802. 10.1001/jama.2013.1625.
45. Smolen K.K., Gelinas L., Franzen L., Dobson S., Dawar M., Ogilvie G., et al. Age of recipient and number of doses differentially impact human B and T cell immune memory responses to HPV vaccination. Vaccine 2012, 30(24):3572-3579. 10.1016/j.vaccine.2012.03.051.
46. Zimmerman R.K., Nowalk M.P., Lin C.J., Fox D.E., Ko F.S., Wettick E., et al. Randomized trial of an alternate human papillomavirus vaccine administration schedule in college-aged women. J Womens Health 2010, 19(8):1441-1447. 10.1089/jwh.2009.1753.
47. Safaeian M., Porras C., Pan Y., Kreimer A., Schiller J.T., Gonzalez P., et al. Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica vaccine trial. Cancer Prev Res 2013, 6:1242-1250. 10.1158/1940-6207.CAPR-13-0203.
48. Integrating immunizations into practice Committee Opinion No. 558. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013, 121:897-903. 10.1097/01.AOG. 0000428788.74725.90.
49. Centers for Disease Control and Prevention Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and post licensure vaccine safety monitoring, 2006-2013 - United States. MMWR Morb Mortal Wkly Rep 2013, 62(July (29)):591-595.